Raleigh, N.C. and Austin, Texas – October 18, 2016 – Valencell, the leading innovator in performance biometric data sensor technology, announced today that the Director of its Biometrics Laboratory, Chris Eschbach, Ph.D., HFS, CSCS, will moderate a panel session on wearables accuracy at the Consumer Technology Association (CTA)™ Technology & Standards Forum, taking place in Austin, Texas, October 18 – 20.
The session, The Importance of Accuracy in Biometric Wearables: A Case for Standards, will examine how standards will help the wearable tech industry accelerate adoption and growth by enabling interoperability across technologies and ecosystems, in addition to outlining benchmarks and protocols for validating biometric wearable sensors. Panelists include representatives from The Fitness Industry Technology Council, Validic, Under Armour, Consumer Technology Association, Philips, and Cardiovascular Health Innovations. The session will take place on Wednesday, October 19th from 1:30 – 2:30 p.m. at the Renaissance Austin Hotel.
The CTA Technology & Standards Forum is an event where engineers, product managers and members of technology alliances gather to network, share information, and develop standards for the consumer electronics industry.
“We know that for fitness wearables, accuracy is the top priority for consumers and necessary for a continually compelling user experience,” said Eschbach, Director, Biometrics Laboratory for Valencell. “Therefore, it is critical that we work together as an industry to establish benchmarks for accuracy and performance, in order to drive continued innovation and growth in the market.”
Valencell’s PerformTek® sensor systems provide accurate, robust and flexible technology, powering more biometric hearables and wearables on the market than any other company. The technology gives hearable devices the ability to continuously and accurately measure blood flow signals, even during extreme physical activity or when the optical signals are weak. These signals can be translated into biometric data, including continuous heart rate, VO2 and VO2 max, resting heart rate, heart rate response, heart rate recovery, continuous energy expenditure (calorie burn), cardiac efficiency and heart rate variability assessments.
The accuracy of Valencell’s PerformTek technology has been independently validated by numerous research institutions, including Duke University, NC State University, and the American College of Sports Medicine.
Valencell licenses its biometric sensor technology to enable customers to create custom-designed biometric wearable devices. Valencell also recently introduced its Benchmark™ sensor system, which incorporates all of Valencell’s PerformTek biometric sensor technology in a pre-packaged system for immediate integration in wearables of all kinds.
Valencell has a highly cited patent portfolio in optical biometric sensor technology in the wearables and hearables industry, which includes 37 patents granted and more than 70 additional patents pending.
Valencell’s PerformTek technology is the choice of popular consumer electronics brands, including Samsung, Sony, LG, Intel/SMS Audio, Jabra, Scosche, Atlas Wearables, Caeden, Kuaiwear, Bioconnected, and iriver among numerous others. To learn more about licensing PerformTek, visit valencell.com/access.
For more information, or to set up a meeting with Chris Eschbach at the CTA Technology & Standards Forum, please contact email@example.com.
Valencell develops performance biometric sensor technology and provides this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products. Valencell’s PerformTek® biometric sensor technology employs active signal characterization, the process of segmenting raw signal data from biometric sensors into biological, motion, and environmental signals and noise. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.